logo

For the Inventor, By the Inventor

Vanloese, Denmark

Ulrich Sensfuss

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Valby, DK (2009)
  • Copenhagen, DK (2009 - 2016)
  • Copenhaven V, DK (2016)
  • Vanloese, DK (2017 - 2020)

Company Filing History:

goldMedal9 out of 1,778 
 
Novo Nordisk A/s
 patents

Years Active: 2009-2020

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 10570184 - GLP-1/glucagon receptor co-agonists for medical use (2020-02-25),
2. 9988430 - Stable GLP-1 based GLP-1/glucagon receptor co-agonists (2018-06-05),
3. 9751927 - Stable, protracted GLP-1/glucagon receptor co-agonists for medical use (2017-09-05),
4. 9486506 - Glucagon analogues (2016-11-08),
5. 9486505 - Glucagon analogues (2016-11-08),
6. 9474790 - Stable, protracted GLP-1/glucagon receptor co-agonists for medical use (2016-10-25),
7. 8541368 - Glucagon analogues (2013-09-24),
8. 7541430 - Peptides for use in treating obesity (2009-06-02),
9. 7517854 - Melanocortin receptor agonists (2009-04-14),

Title: Inventor Ulrich Sensfuss

Introduction: Ulrich Sensfuss is a renowned inventor based in Vanloese, Denmark, known for his groundbreaking contributions to various industries.

Latest Patents: Ulrich Sensfuss holds several patents in the fields of renewable energy, sustainable technologies, and advanced materials.

Career Highlights: With a career spanning over two decades, Sensfuss has worked with leading research institutions and universities to develop innovative solutions for global challenges.

Collaborations: Throughout his career, Ulrich Sensfuss has collaborated with multinational companies, startups, and government agencies to bring his inventions to the market successfully.

Conclusion: Ulrich Sensfuss continues to be a driving force in the world of innovation, with his work making a significant impact on society and the environment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…